Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
FNMFO FNMFO 096770 KDDIF Office Supplies Beers Macroaxis 15 Education 
United States  USA  |  Company Directory


Processing
Collecting data for SSH

Sunshine quote and profile

 
 Companies |  Insiders  | Dashboard  
     
5.69
  
STOCK
0.20  Macroaxis: 3.64 Up   3.64%  
Year To Date
2.517.25
Trading Day 
5.525.74
May 20 2013 

Diversification Suggestion

Use Sunshine to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals
Analyze Sunshine Heart Trend or Check current 30 days Sunshine correlation with market (S&P 500)
1 Month Beta 1.19  
Highest Price:  
Lowest Price:  
5.49  
4.93  
May 17 2013 
April 22 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Sunshine will likely underperform.
Sunshine Heart Inc Large BetaSunshine Heart Beta Legend
SSH United States Nasdaq
Sunshine Heart Inc
http://www.sunshineheart.com
Contact Number: 952. 345. 4200
Currency: USD - US Dollar
Traded on Nasdaq Capital Markets
    
Current Valuation34.28 M
Shares Outstanding9.51 M
Number of Shares Shorted331.03 K
Cash and Equivalents14.22 M
 thisGreen SSH SSH agains markets  3.64 % Macroaxis: change 3.64 Moved Up  
 
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.17 % Macroaxis: 0.17 Moved Up  
 
 United States NYSE   0.12 % Macroaxis: 0.12 Moved Up  
 
 United States SP 500   0.07 % Macroaxis: 0.07 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Sunshine Leadership

David MBA CEO and President and Director
David Rosa CEO, Executive Director
John Erb Chairman of the Board
Nicholas Callinan Independent Non-Executive Chairman of the Board

Sunshine Price and Market Media

The median price of Sunshine for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 5.12 with a coefficient of variation of 3.16. The daily time series for the period is distributed with a sample standard deviation of 0.16, arithmetic mean of 5.16, and mean deviation of 0.12. The Stock received substential amount of media coverage during this period.
Sunshine         Market
Price Growth (%)
 
1
MediPoint Cardiac Assist Devices US Analysis and Market Fore...04/23/2013Macroaxis: MarketWatch News
2
First Nighter Diane Paulus Pippin Flies Through the Air With...04/26/2013Macroaxis: News
3
Sunshine is good for the heart05/09/2013Macroaxis: News
4
New Buffalo ARTigras Expose yourself to great art in Harbor ...05/13/2013Macroaxis: News
5
Art Festival Season Kicksoff in Barrington Over Memorial Day...05/15/2013Macroaxis: News
6
Lou Kohlmann The old days of newspapers are gone but the cha...05/17/2013Macroaxis: News

Sunshine Summary

Sunshine Heart Inc [SSH] is traded on Nasdaq Capital Markets in USA. It is located in Eden Prairie, MN and employs 29 people. The company currently falls under 'Micro-Cap' category with total capitalization of 48.88 M. Sunshine Heart Inc has 9.51 M outstanding shares of which 331.03 K shares are at this time shorted by investors with about 3.6 days to cover shorted positions.
Sunshine Heart, Inc., an earlystage medical device company, focuses on developing, manufacturing, and commercializing CPulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. more
Past Market
Over 30
Days
15
Out Of
100
 
Chance of
More
Than
96 %
 
Follow Sunshine with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Sunshine to your reader
 

Sunshine Research Report

Sunshine vs. Federal

Correlation analysis and fundamentals comparison between Sunshine Heart and Federal National Mor

Sunshine Executives

Jeffrey Mathiesen CFO, Principal Accounting Officer and Company Secretary

Sunshine Directors

Donal ODwyer Non-Executive Independent Director
Gregory Waller Independent Non-Executive Director
Mark Harvey Non-Executive Director, MBA
MD MBChB Co-Founder, Chief Technical Officer and Medical Director
Jon Salveson Director

Sunshine Management

Debra Kridner Executive VP of Clinical Research and Regulatory Affairs
Kevin Bassett Sr. VP of Technology and Operations

Sunshine Fundamentals

Current Liabilities vs One Year Low
Price to Book vs Retained Earnings
Current Liabilities vs Current Valuation
Cash and Equivalents vs Retained Earnings

Sunshine vs Competition

Sunshine vs. Federal National Mortgage Association
Sunshine vs. Federal National Mortgage Association
Sunshine vs. SK Innovation
Sunshine vs. KDDI Corp
Sunshine vs. Japan Tobacco Inc
Sunshine vs. Inpex Corporation
Sunshine vs. AP M
Sunshine vs. AP M
Sunshine vs. Citigroup Inc
Sunshine vs. Akbank TAS

Sunshine May 20 2013 Opportunity Range

Downside Deviation1.42
Information Ratio0.1183
Maximum Drawdown7.16
Value At Risk(1.78)
Potential Upside3.19

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium